LumiraDx (LumiraDx) Land And Improvements : $0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Land And Improvements?

LumiraDx's land and improvements for the quarter that ended in Jun. 2023 was $0.00 Mil.

LumiraDx's annual land and improvements increased from Dec. 2020 ($7.11 Mil) to Dec. 2021 ($34.52 Mil) but then declined from Dec. 2021 ($34.52 Mil) to Dec. 2022 ($0.00 Mil).

LumiraDx Land And Improvements Historical Data

The historical data trend for LumiraDx's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Land And Improvements Chart

LumiraDx Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Land And Improvements

7.11

34.52

LumiraDx Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Land And Improvements	Get a 7-Day Free Trial								32.97	-	-	-	-

LumiraDx Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

LumiraDx (LumiraDx) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDWF) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

LMDXF:USA

Address

C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108

Website

https://www.lumiradx.com

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.